ANTERIOR SEGMENT NEOVASCULARISATION

ANTERIOR SEGMENT NEOVASCULARISATION was reported 12 times

ANTERIOR SEGMENT NEOVASCULARISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 1 0.0017
1 Antiseptic [EPC] 2 0.0005
2 Complement Inhibitor [EPC] 8 0.0001
3 Radioligand Therapeutic Agent [EPC] 1 0.0001
4 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
7 Sulfonylurea [EPC] 1 0.0000
8 Corticosteroid [EPC] 1 0.0000